deferiprone has been researched along with Nephrogenic Systemic Fibrosis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Excerpt | Relevance | Reference |
---|---|---|
"Nephrogenic systemic fibrosis is associated with gadolinium contrast exposure in patients with reduced kidney function and carries high morbidity and mortality." | 3.81 | Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis. ( Bose, C; Hall, KA; Hiatt, KM; Karaduta, O; Megyesi, JK; Shah, SV; Swaminathan, S, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bose, C | 1 |
Megyesi, JK | 1 |
Shah, SV | 1 |
Hiatt, KM | 1 |
Hall, KA | 1 |
Karaduta, O | 1 |
Swaminathan, S | 1 |
1 other study available for deferiprone and Nephrogenic Systemic Fibrosis
Article | Year |
---|---|
Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
Topics: Animals; Contrast Media; Deferiprone; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Humans; I | 2015 |